glutathione cisplatin

glutathione cisplatin Overcoming resistance to by inhibition of S-transferases (GSTs) with ethacraplatin micelles in vitro and in vivo Switchable nanoparticles complexing cisplatin for

Name: glutathione cisplatin Overcoming resistance to by inhibition of S-transferases (GSTs) with ethacraplatin micelles in vitro and in vivo Switchable nanoparticles complexing cisplatin for
Brand: hopkinsdental.com.au
SKU: 11993318419
Price: 26.73 USD
Availability: InStock
Rating: 4.6759 (30 reviews)

Switchable nanoparticles complexing cisplatin for circumventing glutathione depletion in breast cancer chemotherapy ScienceDirect Frontiers Bismuth Reduces Cisplatin Induced Nephrotoxicity Via Enhancing Glutathione Conjugation and Vesicular Transport Cisplatin in cancer therapy: molecular mechanisms of action PMC glutathione cisplatin cytotoxicity A cisplatin based platinum(IV) prodrug containing a s transferase inhibitor to reverse cisplatin resistance in non small cell lung cancer Glutathione carbon dots as an Pincer movement: Reversing cisplatin resistance based on simultaneous glutathione depletion and glutathione S transferases inhibition by redox responsive degradable organosilica hybrid nanoparticles ScienceDirect Research Overview Chien Lab

SKU: 11993318419 · From hopkinsdental.com.au

4.7

USD26.73 USD66.73

Pay in 4 interest-free payments of $6.68 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 29 - Aug 3

Description

Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration

The role of oxidative stress in skeletal muscle myogenesis and muscle disease

Contemp Clin Trials 45, 6975

Explore our comprehensive Peptide and Endocrine Research family here

Rossi S, Herrine SK, Navarro VJ (2005) Cystinosis as a cause of noncirrhotic portal hypertension

On the other hand, 20 patients (4 males and 16 females, with the age of 41.0 14.1 and 42.9 12.0 years old, respectively) with major depressive disorders were selected as the research objects, and it was found that L-theanine (250 mg/day) treatment for 8 weeks was safe and effective to significantly mitigate the symptoms of depression, anxiety, somnipathy, and cognitive disorder (67)